NCT05466734View on ClinicalTrials.gov

BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

August 23, 2022

Study Completion Date

September 20, 2022

Conditions
Intermittent Claudication
Interventions
DRUG

Cilostazol Tablet 100 mg

Two oral doses (total daily dose of 200 mg)

DRUG

PMR Tablet 135 mg

Single oral dose (total daily dose of 270 mg)

Trial Locations (1)

65802

Bio-Kinetic Clinical Applications, LLC, Springfield

Sponsors
All Listed Sponsors
lead

Genovate Biotechnology Co., Ltd.,

INDUSTRY

NCT05466734 - BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers | Biotech Hunter | Biotech Hunter